Vagal Afferent Neurons as Targets for Treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090048194A1
SERIAL NO

11815688

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of identifying a compound capable of reducing or preventing prolonged sensory neuron hyper-excitability comprising the steps of: (a) administering the compound to an experimental non-human animal having prolonged sensory neuron hyper-excitability; (b) generating an expression profile of the genes modulated in the Nodose Ganglia (NG) of the animal of step (a); (c) comparing the expression profile obtained in (b) with the expression profile of a corresponding panel of genes expressed in the NG of an experimental non-human animal having no prolonged sensory neuron hyper-excitability; wherein a positive correlation of the expression profiles is indicative that the compound is capable of reducing or preventing prolonged sensory neuron hyper-excitability in NG.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOLBURN BIOMEDICAL CORPORATION1100 BENNETT ROAD BOWMANVILLE ONTARIO L1C 3K5

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aerssens, Jeroen Marcel Maria Roger Nieuwrode , BE 6 56
Coulie, Bernard Herent , BE 1 51
Grundy, David Sheffield , GB 3 51
Hillsley, Kirk Millbrook , CA 1 51
Meulemans, Ann Louise Gabrielle Mol , BE 5 89
Peeters, Pieter Johau Dessel , BE 1 51
Stead, Ronald Bowmanville , CA 3 60

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation